Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells--protection by carbonyl scavengers
- PMID: 16781798
- DOI: 10.1016/j.neurobiolaging.2006.05.007
Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells--protection by carbonyl scavengers
Abstract
Advanced glycation end products (AGEs) are found in various intraneuronal protein deposits such as neurofibrillary tangles in Alzheimer's disease and Lewy bodies in Parkinson's disease. Among the many reactive carbonyl compounds and AGE precursors, methylglyoxal is most likely to contribute to intracellular AGE formation, since it is extremely reactive and constantly produced by degradation of triosephosphates. Furthermore, methylglyoxal levels increase under pathophysiological conditions, for example, when trisosephosphate levels are elevated, the expression or activity of glyoxalase I is decreased, as is the case when the concentration of reduced glutathione, the rate-determining co-factor of glyoxalase I, is low. However, the effects of methylglyoxal on mitochondrial function and energy levels have not been studied in detail. In this study, we show that methylglyoxal increases the formation of intracellular reactive oxygen species and lactate in SH-SY5Y neuroblastoma cells. Methylglyoxal also decreases mitochondrial membrane potential and intracellular ATP levels, suggesting that carbonyl stress-induced loss of mitochondrial integrity could contribute to the cytotoxicity of methylglyoxal. The methylglyoxal-induced effects such as ATP depletion and mitochondrial dysfunction can be prevented by pre-incubation of the cells with the carbonyl scavengers aminoguanidine and tenilsetam. In a clinical context, these compounds could not only offer a promising therapeutic strategy to reduce intracellular AGE-accumulation, but also to decrease the dicarbonyl-induced impairment of energy production in aging and neurodegeneration.
Similar articles
-
Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity.Free Radic Biol Med. 2006 Mar 1;40(5):779-90. doi: 10.1016/j.freeradbiomed.2005.09.038. Epub 2005 Nov 2. Free Radic Biol Med. 2006. PMID: 16520230
-
Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.J Neurosci Res. 2006 Jun;83(8):1591-600. doi: 10.1002/jnr.20838. J Neurosci Res. 2006. PMID: 16555297
-
The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal.Neurotox Res. 2005;7(1-2):95-101. doi: 10.1007/BF03033780. Neurotox Res. 2005. PMID: 15639802
-
Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?Exp Gerontol. 2010 Oct;45(10):744-51. doi: 10.1016/j.exger.2010.03.001. Epub 2010 Mar 6. Exp Gerontol. 2010. PMID: 20211718 Review.
-
Oxidative stress and aging: is methylglyoxal the hidden enemy?Can J Physiol Pharmacol. 2010 Mar;88(3):273-84. doi: 10.1139/Y10-001. Can J Physiol Pharmacol. 2010. PMID: 20393592 Review.
Cited by
-
Promotion of Mitochondrial Protection by Emodin in Methylglyoxal-Treated Human Neuroblastoma SH-SY5Y Cells: Involvement of the AMPK/Nrf2/HO-1 Axis.Neurotox Res. 2021 Apr;39(2):292-304. doi: 10.1007/s12640-020-00287-w. Epub 2020 Sep 15. Neurotox Res. 2021. PMID: 32930996
-
Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation.Sci Rep. 2016 Mar 21;6:23403. doi: 10.1038/srep23403. Sci Rep. 2016. PMID: 26997114 Free PMC article.
-
Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway.Front Pharmacol. 2020 May 29;11:805. doi: 10.3389/fphar.2020.00805. eCollection 2020. Front Pharmacol. 2020. PMID: 32547400 Free PMC article.
-
Methylglyoxal-induced neuroinflammatory response in in vitro astrocytic cultures and hippocampus of experimental animals.Metab Brain Dis. 2016 Oct;31(5):1055-64. doi: 10.1007/s11011-016-9849-3. Epub 2016 Jun 2. Metab Brain Dis. 2016. PMID: 27250968
-
Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury.Acta Pharmacol Sin. 2011 Aug;32(8):991-8. doi: 10.1038/aps.2011.81. Epub 2011 Jul 18. Acta Pharmacol Sin. 2011. PMID: 21765445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources